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Abstract
Sympathetic hyperactivity induces adverse effects in myocardial. Recent studies have shown that exercise training induces
cardioprotection against sympathetic overload; however, relevant mechanisms of this issue remain unclear. We analyzed
whether exercise can prevent pathological hypertrophy induced by sympathetic hyperactivity with modulation of the
kallikrein-kinin and angiogenesis pathways. Male Wistar rats were assigned to non-trained group that received vehicle; non-
trained isoproterenol treated group (Iso, 0.3 mg kg21 day21); and trained group (Iso+Exe) which was subjected to
sympathetic hyperactivity with isoproterenol. The Iso rats showed hypertrophy and myocardial dysfunction with reduced
force development and relaxation of muscle. The isoproterenol induced severe fibrosis, apoptosis and reduced myocardial
capillary. Interestingly, exercise blunted hypertrophy, myocardial dysfunction, fibrosis, apoptosis and capillary decreases.
The sympathetic hyperactivity was associated with high abundance of ANF mRNA and b-MHC mRNA, which was
significantly attenuated by exercise. The tissue kallikrein was augmented in the Iso+Exe group, and kinin B1 receptor mRNA
was increased in the Iso group. Moreover, exercise induced an increase of kinin B2 receptor mRNA in myocardial. The
myocardial content of eNOS, VEGF, VEGF receptor 2, pAkt and Bcl-2 were increased in the Iso+Exe group. Likewise,
increased expression of pro-apoptotic Bad in the Iso rats was prevented by prior exercise. Our results represent the first
demonstration that exercise can modulate kallikrein-kinin and angiogenesis pathways in the myocardial on sympathetic
hyperactivity. These findings suggest that kallikrein-kinin and angiogenesis may have a key role in protecting the heart.
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Introduction
Initial activation of cardiac sympathetic drive is observed in
chronic heart failure, and it is followed by increased and
generalized sympathetic stimulation [1]. Common consequences
of sympathetic hyperactivity are negative effects on the heart, such
as injury, hypertrophy, and dysfunction [2,3].
Exercise training exerts several positive effects on the cardio-
vascular system, such as improved heart function [4,5]. Moreover,
cardioprotective effects of exercise have been extensively described
[6]. It was shown that isoproterenol caused hypertrophy, necrosis,
apoptosis, fibrosis, and reduced capillary size in the left ventricle
(LV) [7]; interestingly, all negative effects of sympathetic hyper-
activity were prevented by exercise. In a previous study, we
showed that exercise blunted isoproterenol-induced LV hypertro-
phy as well as improved myocardial performance. These findings
were associated with inhibition of pro-inflammatory cytokines in
the myocardium [8].
The kallikrein-kinin system is recognized as an important
modulator of the cardiovascular system [9,10]. Tissue kallikrein, a
major member of the ubiquitously expressed kallikrein family,
releases kinin (bradykinin and kallidin) from kininogen [11].
Kinins exert their action through two G-protein-coupled recep-
tors, kinin B1 and B2 receptors [12]. Whereas the kinin B2 receptor
is constitutively expressed in several tissues and cell lines under
physiological conditions, the kinin B1 receptor normally has very
low expression; however, under pathological conditions, particu-
larly inflammation, the kinin B1 receptor is synthesized and
expressed de novo [12].
As noticed for exercise, cardiac hypertrophy and dysfunction
were induced as a result of sympathetic hyperactivity that can be
attenuated by kinin [13]. In a transgenic rat model harboring
human tissue kallikrein, we found that isoproterenol induced less
cardiac hypertrophy as indicated by reduction in markers
associated with growth and fibrosis. We also observed that the
kinin B2 receptor antagonist with icatibant eliminated the
cardioprotective effects [13].
Analyzing the occurrence of hypotension as a result of
physiological adaptation to exercise, some authors have shown
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that plasma kallikrein activity and bradykinin content increased
after exercise [14]. This finding reveals that the cardioprotective
effects of exercise against sympathetic hyperactivity may exist with
participation of kallikrein-kinin components. We addressed this
issue using a well-established experimental model of sympathetic
hyperactivity with isoproterenol.
To evaluate the cardioprotective effect of exercise, rats were
subjected to isoproterenol after a previous program of aerobic
training. We then evaluated several markers expressed under
pathologic hypertrophy, including expression of hypertrophic
genes, myocytes ultrastructure and fibrosis, myocardial dysfunc-
tion, angiogenesis, and apoptosis.
Materials and Methods
Ethics Statement
The investigation was designed in accordance with The Guide
for the Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH publication no. 85–23, revised
1996). This experimental protocol conformed to government and
institutional animal welfare guidelines and was approved by the
official animal ethics committee of the Universidade Nove de
Julho, Brazil (Process number: 0015/2012) prior to the execution
of the experiments. All surgery was performed under conditions to
minimize suffering.
Animals
Thirty-four male Wistar rats, weighing 160–190 g, were
randomly assigned to one of the following groups: Con (n=12),
non-trained rats that received vehicle subcutaneously (olive oil,
1 ml); Iso (n=13) non-trained rats that received isoproterenol
injections (0.3 mg kg21 day21) diluted in 1 ml of olive oil; and
Iso+Exe (n=9), trained rats which were subjected to sympathetic
hyperactivity with isoproterenol (0.3 mg kg21 day21).
Exercise training program
The animals were subjected to running on a motor-driven
treadmill for 13 weeks as previously reported [7]. Briefly, animals
were made to run on a treadmill for 1 h per day, 6 days per week.
The treadmill speed was set at 18 m/min for the first 30 min and
was increased to 22 m/min for the remaining 30 min of exercise.
The rats were preconditioned to treadmill running for 12
consecutive days before main protocol. The treadmill speed was
progressively increased by 3 m/min every 2 days until the final
speed of 18 m/min was reached. The sessions initially lasted for
5 min and were increased by 5 min each day to reach 60 min on
day 12. The isoproterenol or olive oil was administered on the last
day of week 12 and on all seven days of week 13 of exercise, to
achieve 8 days of treatment. Twenty-four hours after the last
exercise session, rats were anesthetized (overdose urethane: 4.8 g/
kg i.p.) and sacrificed.
Myocardial mass, nuclear volume and hypertrophic
genes
The LV was rapidly excised after euthanasia, washed, and
whole LV mass was recorded. The LV was fixed in 10% neutral
buffered formalin, embedded in paraffin, sectioned in 7 mm
thickness, and stained with haematoxylin–eosin according to
standard protocols. The nuclear length (major diameter) and
width (minor diameter) of longitudinal cardiomyocyte sections
were measured on Olympus microscope at 406 magnification.
Fifty nuclei from each animal was evaluated and nuclear volume
was estimated from the formula for a prolate ellipsoid with Image
Tool software 3.0 [7]. Frozen LV was performed as described
below for gene expression of atrial natriuretic factor (ANF) and
beta-myosin heavy chain (b-MHC).
Myocardial performance
The myocardial performance was evaluated in posterior
papillary muscle removed of LV as described in a previous
publication [8]. The muscle were placed in a tissue bath
containing modified Krebs–Henseleit solution (mM: 130 NaCl,
5.0 KCl, 1.2 MgCl2, 1.5 CaCl2, 11 glucose, 20 U insulin and 20
Hepes) bubbled with 100% O2 and maintained at 29uC, pH 7.4).
The muscles were loaded to contract isometrically at a Grass FTO
force transducer (Astro-Med Inc., Grass Instrument Division, West
Warwick, RI, USA) and stretched to the apices of their length–
tension curves with a micromanipulator (Mitutoyo, model 2046 F,
Sa˜o Paulo, Brazil. The parameters were recorded through the use
of AcqKnowledge 3.5.7 software (Biopac Systems Inc.) for
determination of peak developed tension (DT), maximal rate of
tension increase (+dT/dt) and decrease (2dT/dt). The respective
values were normalized as a ratio of the cross-sectional area and
papillary muscle mass [15].
Collagen tissue staining
The LV fixed in 10% neutral buffered formalin was performed
as described above. The tissue was stained with picrosirius red and
collagen content was analyzed using polarized light observation on
Olympus microscope at 406 magnification with Image Tool
software 3.0 [7].
Transmission electronic microscopy
Ultrastructural myocardial evaluation was performed in three
rats from each group by electron microscopy. The LV fragments
were cut into small 1 mm thick pieces, post-fixed in 1% OsO4
solution for 2 h at 4uC, and then dehydrated and embedded in
araldite. Silver or grey thin sections were cut on a Porter- Blum
MT-B ultra microtome, mounted on copper grids and stained with
uranyl acetate and lead citrate. Preparations were examined
through a Philips EM-301 microscope and photographed at
16506magnification. Five representative microphotographs from
each rat were registered to evaluate the capillary numbers per
area.
TUNEL staining
To detect apoptotic cells, a TUNEL assay was performed in 2-
cm long, 5-mm thick paraffin embedded, formalin-fixed myocar-
dial sections. Tissue sections were prepared as previously described
[7]. The number of TUNEL-positive cells per area was counted
using 206magnification in ten representative microphotographs
from each rat.
Gene expression quantification
To evaluate mRNA, total RNA was extracted from LV with
1 ml of TRIzol reagent (Gibco BRL, Gaithersburg, MD)
accordingly to the manufacturer’s instructions. One microgram
of total RNA was used for cDNA synthesis and Real-Time PCR
gene expression analysis. Initially, contaminating DNA was
removed using DNase I (Invitrogen) at a concentration of
1 unit/mg RNA in the presence of 20 mM Tris-HCl, pH 8.4,
containing 2 mM MgCl2for 15 min at 37uC, followed by
incubation at 95uC for 5 min for enzyme inactivation. Then, the
reverse transcription (RT) was carried out in a 200 ml reaction in
the presence of 50 Mm Tris-HCl, pH 8.3, 3 mM MgCl2, 10 mM
dithiothreitol, 0.5 mM dNTPs, and 50 ng of random primers with
200 units of Moloney murine leukemia virus-reverse transcriptase
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(Invitrogen). The reactions conditions were: 20uC for 10 min,
42uC for 45 min and 95uC for 5 min. The reaction product was
amplified by real time PCR on the 7500 Sequence Detection
System (ABI Prism, Applied Biosystems, Foster City, CA, USA)
using the SYBRGreen core reaction kit (ABI Prism, Applied
Biosystems, Foster City, CA, USA). The thermal cycling
conditions were: 50uC for 2 min, then 95uC for 10 min, followed
by 40 cycles at 95uC for 15 s and 60uC for 1 min. Experiments
were performed in triplicates for each data point. Primers used for
realtime PCR were: rat glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH) forward primer 59-TGCACCACCAACTGCT-
TAGC-39 and reverse primer 59-GCCCCACGGCCATCA-39
(GenBank number: NM_017008); rat ANF primers forward 59-
AGCGAGCAGACCGATGAAGC-39 reverse 59- GCAGAGTG-
GGAGAGGTAAGGC- 39 (GenBank number: M27498.1); rat b-
MHC primers forward 59- CACTCAACGCCAGGA -39 reverse
59- TTGACAGAACGCTGTGTCTCCT-39 (GenBank number:
X15939.1); rat kinin B1 receptor primers forward 59-CCTT-
CCAGGCTTAAACGATTCTC-39 and reverse 59-GGTTGGA-
GG ATTGGAGCTCTAGA-39 (GenBank number: NM_03085
1.1); rat kinin B2 receptor primers forward 59-CCACCACG-
GCCTCTTTCAG-39 and reverse 59-CGAACAGCACCCA-
GAGGAA-39 (GenBank number: NM_001270713.1); rat tissue
kallikrein primers forward 59- TGTCATCAACAGATACCTC-
TG-39 and reverse 59- GCATGATCTGTCACCATCTGT-39
(GenBank number: NM_001005382). To access endothelial nitric
oxide synthase (eNOS), vascular endothelial growth factor (VEGF)
and VEGF receptor 2 mRNA quantification: rat eNOS forward
59-TGCTGCCCGAGATATCTTCAGT-39 and reverse 59-
GGCTGCCTTTTTCCAGTT GTTC-39 (GenBank number:
AJ011116), rat VEGF forward 59-ACAGAAGGGGAGCAGAA-
AGCCCAT-39 and reverse 59-CGCTCTGACCAAG GCTCA-
CAGT-39 (GenBank number: AF222779.1); rat VEGF receptor 2
primers forward 59-TGGGGGAGCGTGTCAGAAT-39 and
reverse 59-CCGCTTTAATTGTGTGATTGAC-39 (GenBank
number: NM_002253). One microliter of RT reaction was used
for Real-Time PCR. Target gene mRNA abundance was
quantified as a relative value compared with the internal GAPDH
reference.
Western blot analysis
Frozen LV was homogenized in cell lysis buffer (100 mM Tris,
pH 7.6, 50 mM NaCl, 10 mM EDTA and 1% Triton X-100)
supplied with a proteinase inhibitor cocktail (Sigma Chemical
Corp., St Louis, MO, USA). Samples containing 30 mg of the
homogenate were subjected to SDS-PAGE in 10% polyacrylamide
gels. Separated proteins were transferred onto Hydrophobic
Polyvinylidene membranes (Hybond-P, Amersham Biosciences;
Piscataway, NJ, USA), and transfer efficiency was monitored with
0.5% Ponceau S staining. Membranes were soaked in a blocking
buffer (5% non-fat dry milk, 10 mM Tris–HCl, pH 7.6, 150 mM
NaCl and 0.1% Tween 20) for 2 h at room temperature and then
incubated overnight at 4uC using specific antibodies: goat anti-
kallikrein (1:500 dilution; Santa Cruz Biotechnology, Santa Cruz,
CA, USA); goat anti-VEGF (1:200 dilution; Abcam, Cambridge,
MA, USA); goat anti-VEGFr2 (1:200 dilution; Abcam, Cam-
bridge, MA, USA); rabbit anti-protein kinase B (Akt, 1:200
dilution; Santa Cruz Biotechnology, Inc); rabbit anti-phos-
pho(S473)-Akt (1:200 dilution; Santa Cruz Biotechnology, Inc);
mouse anti-B cell lymphoma 2 (Bcl-2, 1:200 dilution; Santa Cruz
Biotechnology, Inc); and rabbit anti-Bcl-2 associated death
promoter (Bad,1:200 dilution; Santa Cruz Biotechnology, Inc.).
After incubation, membranes were washed three times and then
incubated for 1 h at room temperature with horseradish
peroxidase-conjugated secondary antibodies (1:5000 dilution;
Zymed, San Franscisco, CA, USA). The detection was performed
with chemiluminescence reagents (Amersham Biosciences, Piscat-
away, NJ, USA) and values for target protein were normalized to
GAPDH.
Statistical analysis
The Shapiro-Wilk test was used to verify approximately normal
statistic distributions. The Levene test was used to assess the
equality of variances. One way ANOVA followed by Newman–
Keuls test was used to detect differences between groups using
GraphPad Prism software (version 4.0, GraphPad Software, Inc,
La Jolla, CA, USA). A p value,0.05 was considered as significant.
Results
Exercise inhibits myocardial hypertrophy induced by
isoproterenol
Body weight and LV mass were analyzed for each animal.
Sedentary isoproterenol-treated rats had significantly higher body
weight compared to the other groups (Figure 1A). In sedentary
rats, 8 days of isoproterenol significantly increased LV mass
compared with sedentary rats that only received vehicle
(Figure 1B/1C). As indicated in Figure 1, there was a clear
impact of exercise on LV enlargement; therefore, trained rats
showed inhibition of myocardial growth. Since nuclear augmen-
tation is associated with cellular growth [16], LV hypertrophy was
confirmed by nuclear volume increase in the Iso group (Figure 1D).
Exercise blunted increase in this indicator of cellular hypertrophy.
Pathologic cardiac hypertrophy induced by the isoproterenol
model is characterized by the induction of genes normally
expressed during fetal development, such as ANF and b-MHC
[17]. We evaluated whether exercise prevented the induction of
ANF and b-MHC in hypertrophy induced by isoproterenol.
Consistent with previous findings, there was increased expression
of ANF and b-MHC mRNA in the Iso group (Figure 1D).
However, exercised animals expressed significantly less ANF and
b-MHC mRNA than sedentary isoproterenol-treated rats.
Exercise confers myocardial performance protection from
isoproterenol
With respect to myocardial performance, we confirmed findings
of previous studies in which sustained sympathetic hyperactivity
resulted in muscles that developed less force than their respective
controls [18,19]. In our case, the negative effect is depicted as a
reduction in DT (Figure 2A) and +dT/dt (Figure 2B). Moreover,
2dT/dt (an indicator of myocardial relaxation) was significantly
reduced in the sympathetic stimulated non-trained rats compared
with non-trained rats that received only vehicle (Figure 2C).
Exercised rats subjected to isoproterenol treatment showed that
myocardial dysfunction was prevented by exercise.
There is no expansion of collagen fibers in the myocardia
of exercised rats treated with isoproterenol
Myocardial fibrosis is a well-established finding associated with
isoproterenol-induced sympathetic hyperactivity. Given that the
accumulation of collagen has been reported to impair myocardial
performance [20], we wanted to test whether exercise could be
cardioprotective in cardiac remodeling. As evidenced in Figure 3,
quantitative analysis for picrosirius red polarization indicated a
significantly larger fractional area of collagen in the Iso group.
Notably, isoproterenol treatment showed no discernible effect on
collagen content in the LV of exercised animals.
Cardioprotection and Exercise Training
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Figure 1. Effects of exercise training on the myocardial hypertrophy induced by sympathetic hyperactivity. Panel A, Body weight was
evaluated at the end of study. Panel B, Absolute left ventricular (LV) mass of each experimental group. Panel C, LV mass was indexed by body weight
of each animal. Panel D, Representative light micrographs of myocardial section stained with haematoxylin–eosin. Arrows indicate the cardiomyocyte
nucleus on longitudinal orientation. The graph shows the results for nuclear volume of each experimental group. Panel E, Expression of hypertrophic
mRNA markers for each experimental group determined by quantitative real-time RT-PCR. Same letters above bars into graphs indicate values not
different in ANOVA. Different letters above bars into graphs indicate significant difference between means.
doi:10.1371/journal.pone.0091017.g001
Figure 2. Exercise training inhibits myocardial dysfunction induced by sympathetic hyperactivity. Data were obtained at muscle lengths
corresponding to 100% of Lmax. Panel A, Peak developed tension (DT). Panel B, Maximal positive time derivative of developed tension (+dT/dt).
Panel C, Maximal negative time derivative of developed tension (2dT/dt). Same letters above bars into graphs indicate values not different in
ANOVA. Different letters above bars into graphs indicate significant difference between means.
doi:10.1371/journal.pone.0091017.g002
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Capillary reduction and apoptosis are inhibited in
exercised rats even after treatment with isoproterenol
It has previously been shown that exercise leads to the
preservation of capillaries in the myocardium and may inhibit cell
death by apoptosis [7,8]. As expected, ultrastructural analysis of
sedentary isoproterenol-treated rats showed significant reduction of
capillaries in the myocardium (Figure 3). Moreover, there was a
marked increase in cell death by apoptosis with isoproterenol
injections. Interestingly, deleterious effects of sympathetic hyperac-
tivity on capillary and cell death were prevented by exercise.
Exercise promotes differential expression of kallikrein-
kinin components in rats treated with isoproterenol
The gene expression assay revealed that tissue kallikrein
increased significantly in the Iso+Exe group when compared to
control animals or those that only received isoproterenol
Figure 3. Collagen content, capillary density and apoptosis are preserved in exercised rats on sympathetic hyperactivity. Panel A–C,
Representative polarized light micrographs of tissue stained with picrosirius red (magnification 406). Panel D–E, Representative electron
micrographs for capillaries visualization (magnification 16506). Panel G–I, TUNEL assay for cardiomyocytes in apoptosis (magnification: 206) as
estimated from cells marked in red (magnification 206). Quantitative analysis for collagen content, capillary density and positive apoptotic cells are
shown in panel J, K and L, respectively. Same letters above bars into graphs indicate values not different in ANOVA. Different letters above bars into
graphs indicate significant difference between means.
doi:10.1371/journal.pone.0091017.g003
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(Figure 4A). There was marked augmentation in tissue kallikrein
protein expression of exercised isoproterenol-treated rats when
compared with the other groups (Figure 4B). As shown in
Figure 3C, sympathetic hyperactivity evoked significant up-
regulation of the kinin B1 receptor at the transcriptional level.
On the other hand, the effects of isoproterenol on kinin B1
receptor mRNA were blunted in the exercised animals. Addition-
ally, increased kinin B2 receptor expression was observed in the
Iso+Exe group compared with the other groups (Figure 4D).
Exercise modulates different components of
angiogenesis and apoptosis pathways
Angiogenesis data are shown in the Figure 5. It can be seen that
8 days of sympathetic hyperactivity did not result in change for
any component in the non-trained rats. However, we showed
significant myocardial up-regulation of VEGF and its type 2
receptor in the trained isoproterenol-treated rats when compared
with the Con and Iso groups (Figure 5A–B/5D–E). The eNOS
mRNA was evaluated because is usually downstream of kinin and
the VEFG pathway (Figure 5C). Thus, gene expression of eNOS
increased in the Iso group compared with the Con group.
Interestingly, exercise also increased eNOS mRNA content after
isoproterenol injections, but its expression was strongly up-
regulated compared with the Iso group.
We also observed that another important target of the kinin/
VEGF pathway, Akt, was activated by exercise. Hence, total Akt
content is not altered by isoproterenol or exercise (Figure 5F);
however, its phosphorylated active form (pAkt) showed a
significant increase in trained isoproterenol-treated rats
(Figure 5G).
Additionally, data for two molecules that are known to
modulate apoptosis are shown in Figure 5. Exercise induced a
significant increase in anti-apoptotic Bcl-2 protein expression after
isoproterenol treatment (Figure 5H). Nevertheless, the increase of
pro-apoptotic Bad protein expression evoked by sympathetic
overload was blunted by exercise (Figure 5I).
Figure 4. Exercise modulates key components of the kallikrein-kinin pathway in the myocardial on sympathetic hyperactivity. A
significantly up-regulation of gene (Panel A) and protein (Panel B) expression was detected in the trained rats submitted to isoproterenol injection.
The kinin B1 receptor gene was up-regulated in myocardial of sedentary isoproterenol-treated rats, whereas the exercised isoproterenol-treated rats
the kinin B1 receptor gene was normalized (Panel C). Moreover, exercise also increased kinin B1 receptor in transcriptional level (Panel D). Same letters
above bars into graphs indicate values not different in ANOVA. Different letters above bars into graphs indicate significant difference between means.
doi:10.1371/journal.pone.0091017.g004
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Discussion
Exercise training is strongly recommended to improve cardio-
vascular health [21,22]. Our study was designed to test the
hypothesis that cardioprotective effects of exercise on sympathetic
hyperactivity are associated with modulation of key components of
the kallikrein-kinin system and angiogenesis pathway.
Isoproterenol is well known to induce hypertrophy, fibrosis, and
inflammation in the heart when administrated subcutaneously
[13,23,24]. We previously showed that exercised rats had
significant inhibition of deleterious isoproterenol effects [7].
Extension of these findings were published elsewhere, and revealed
that the beneficial role of exercise was accomplished by significant
improvement in myocardial performance [8]. In this study, there
was complete protection from myocardial hypertrophy and
dysfunction in rats that received isoproterenol after exercise.
Fibrosis, apoptosis, and capillary reduction induced by isoproter-
enol were also blunted in exercised rats.
Previous findings have raised interest regarding the possible
mechanisms mediating the cardioprotective actions of exercise on
sympathetic hyperactivity. The prevention of fibrosis, pro-inflam-
matory cytokines, oxidative stress, and apoptosis is of particular
interest [7,8,25]. The present study provides novel information
regarding this issue. We found that the kallikrein-kinin system was
positively modulated in the myocardial of rats on a regular
exercise regime. Thus, tissue kallikrein (a protein key for the
synthesis of bradykinin) expression at transcriptional and transla-
tional levels was augmented. These findings are interesting
considering that cytoprotective effects have been linked to
kallikrein.
It was shown that protection by tissue kallikrein in oxidative
organ damage is attributed to inhibition of apoptosis, inflamma-
tion, hypertrophy, and fibrosis [26]. Tissue kallikrein knockout
mice showed thinning of the LV wall and reduced myocardial
mass compared with wild-type mice. These structural abnormal-
ities were accompanied by reduced cardiac function, which was
observed under basal conditions or acute b-adrenergic stimulation
[27]. Our findings suggest that tissue kallikrein is possibly
participating in prevention of deleterious cardiac effects evoked
by sympathetic hyperactivity in exercised rats. Regarding tissue
kallikrein expression, the protein analysis corroborates gene
expression, indicating that tissue kallikrein is highly formed in
the myocardium.
We showed that isoproterenol increased kinin B1 receptor
mRNA expression, but exercise was able to inhibit this event.
Interestingly, B2 receptor mRNA modulation only occurred in the
exercised animals. There are no data linking deleterious or
protective roles of bradykinin receptors in the heart on sympa-
thetic hyperactivity. Therefore, it is difficult to speculate whether
exercise-induced cardioprotection may be mediated by the
synchronized effect on kinin B1 and B2 receptors. However,
studies indicate a distinct role of these receptors in cardiac
remodeling.
Treatment with kinin B1 receptor antagonist improved cardiac
function after myocardial infarction, as evidenced by attenuation
of elevated LV end diastolic pressure [28]. On the other hand, it
was shown that tissue kallikrein, through the kinin B2 receptor and
NO formation, improves cardiac function, apoptosis, and inflam-
mation, and limits LV remodeling after ischemic injury [29,30].
Additionally, it was shown that B2 receptor knockout mice
subjected to myocardial infarction had a greater cardiomyocyte
cross-sectional area and more interstitial collagen compared with
wild-type controls [31].
Studies have suggested a possible angiogenesis therapy using
tissue kallikrein based on the fact that human tissue kallikrein was
shown to be protective [32]. In our study, we evaluated VEGF
expression and its type 2 receptor. We showed that sympathetic
hyperactivity does not change VEGF and Akt, which is a key
intracellular mediator of this pathway. However, our findings are
in accordance with lines of evidence showing that exercise induces
a local angiogenic phenotype characterized by overexpression of
Figure 5. Exercise modulates key components of the angiogenesis and apoptosis pathway in the myocardial on sympathetic
hyperactivity. It is remarkable that exercise increased mRNA of VEGF (Panel A), VEGF receptor 2 (Panel B) and eNOS (Panel C) in the isoproterenol-
treated rats. The protein levels of VEGF (Panel D) and its receptor (Panel E) were also increased by exercise. Although total Akt protein has not been
changed (Panel F), activated form of Akt was significantly up-regulated in the exercise animals (Panel G). Moreover, a beneficial effect of exercise was
observed for proteins that modulate apoptosis (Panel: H and I). Same letters above bars into graphs indicate values not different in ANOVA. Different
letters above bars into graphs indicate significant difference between means.
doi:10.1371/journal.pone.0091017.g005
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VEGF in the heart [33]. Moreover, we observed high expression
of active Akt form and Bcl-2 (anti-apoptotic) protein as well as a
reduction of pro-apoptotic Bad. These findings have been
previously shown in myocardial injury by ischemia/reperfusion,
hypertension, and diabetes [34,35,36]. Thus, as a novel finding,
we show that the kallikrein-kinin system/VEGF/Akt pathway may
be involved in exercise-induced cardioprotection against sympa-
thetic hyperactivity.
In the current study, one cardioprotective pathway elicited for
kinin and VEGF action could be NO release [37,38]. NO is a
short-lived free radical gas involved in several physiological and
pathological processes. When synthesized by eNOS, NO plays an
important role in endothelial function and cardioprotection
[39,40]. In fact, findings have emphasized that NO may
antagonize sympathetic stimulation [41]. Therefore, our findings
showed an increase of eNOS in exercise rats, suggesting that this
molecule may participate in cytoprotection from the cardiotoxic
effects of catecholamines.
Conclusion
Our results represent the first demonstration that exercise
modulates sympathetic hyperactivity in myocardia by the
kallikrein-kinin system and angiogenesis pathway. The mainte-
nance of capillarity and prevention of hypertrophy, fibrosis
apoptosis, and myocardial dysfunction with exercise are also
promising results. Thus, the kallikrein-kinin system and angiogen-
esis pathway play key roles in protecting the heart from
sympathetic stimulation.
Clinical perspective and limitations
Sympathetic activity increases in a wide range of cardiac
diseases, such as ischemic heart failure [42]. Importantly,
pronounced sympathetic activation has been shown to be inversely
correlated with survival [43]. Our study has important implica-
tions regarding this issue. We used an experimental model of
sympathetic hyperactivity with isoproterenol to test the protective
role of exercise. Hypertrophy, fibrosis, capillary loss, apoptosis,
and myocardial dysfunction were prevented by exercise. These
findings were accompanied by favorable modulation of compo-
nents of the kallikrein-kinin and angiogenesis pathways. Moreover,
assuming that the isoproterenol load used in our study is also
excessive with regard to natural sympathetic stimulation, exercise
can be considered very effective for promoting heart protection
against sympathetic hyperactivity. Importantly, our rat exercise
protocol (1 h per day; 6 days per week; moderate load) was
equivalent to human endurance exercise recommendations for
heart health, for which moderate-intensity exercise training
includes $30 min?d21 on 5 d?wk21 for a total of
$150 min?wk21. In fact, 30–60 min?d21 of moderate exercise
has a strong evidence statement (category A) [44]. In the present
study, there was a limitation that must be considered. Unfortu-
nately, in the current design, it cannot be determined whether the
benefits of exercise training will continue to counteract isoproter-
enol over longer term exposure, which would be more relevant to
chronic human sympathetic hyperactivity.
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